RxDoctor Payments Data

James Doyle, DO

Family Medicine · Monroe, MINPI 1982679262

Payments from drug & device makers

$1,048in general payments, 2019–2025

Across 67 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$197
  • Pfizer$176
  • Axsome Therapeutics, Inc.$116
  • GSK$111
  • AbbVie$99
  • Boehringer Ingelheim$77
  • plus $272 from 7 others

What the payments were for

  • Food & beverage$1,048100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,048 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$33,257
Medicare patients
119
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast11$52,172
EliquisApixaban61$41,682
JardianceEmpagliflozin24$32,806
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$28,736
JanuviaSitagliptin Phosphate17$25,804
OzempicSemaglutide11$18,488
TrulicityDulaglutide13$15,873
XareltoRivaroxaban11$12,700
LantusInsulin Glargine,hum.Rec.Anlog15$6,575
Incruse ElliptaUmeclidinium Bromide18$6,399
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$5,751
Atorvastatin Calcium258$3,679
Losartan Potassium222$3,465
Potassium Chloride78$2,885
Albuterol Sulfate HfaAlbuterol Sulfate72$2,629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$176$41,68261 claims
GSKTrelegy Ellipta, Incruse Ellipta$111$35,13548 claims
Boehringer IngelheimJardiance$77$32,80624 claims
Novo NordiskOzempic, Novolog$60$20,26029 claims
Lilly USA, LLCTrulicity$75$15,87313 claims
Sanofi-aventis U.S. LLCLantus$14$6,57515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Monroe

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →